Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy

被引:5
|
作者
Ellwood, Rebecca A. [1 ,2 ]
Piasecki, Mathew [1 ,2 ]
Szewczyk, Nathaniel J. [1 ,2 ,3 ,4 ]
机构
[1] Univ Nottingham, Med Res Council MRC Versus Arthrit, Ctr Musculoskeletal Ageing Res, Royal Derby Hosp, Derby DE22 3DT, England
[2] Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Derby DE22 3DT, England
[3] Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA
[4] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA
基金
英国生物技术与生命科学研究理事会;
关键词
DMD; C; elegans; dystrophin; muscle; CARBONIC-ANHYDRASE-III; MUSCLE DEGENERATION; MDX MOUSE; ALPHA-CATULIN; BK CHANNEL; DYSTROBREVIN; GENE; INHIBITION; EXPRESSION; INTEGRITY;
D O I
10.3390/ijms22094891
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The nematode worm Caenorhabditis elegans has been used extensively to enhance our understanding of the human neuromuscular disorder Duchenne Muscular Dystrophy (DMD). With new arising clinically relevant models, technologies and treatments, there is a need to reconcile the literature and collate the key findings associated with this model.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Mitochondrial hydrogen sulfide supplementation improves health in the C. elegans Duchenne muscular dystrophy model
    Ellwood, Rebecca A.
    Hewitt, Jennifer E.
    Torregrossa, Roberta
    Philp, Ashleigh M.
    Hardee, Justin P.
    Hughes, Samantha
    van de Klashorst, David
    Gharahdaghi, Nima
    Anupom, Taslim
    Slade, Luke
    Deane, Colleen S.
    Cooke, Michael
    Etheridge, Timothy
    Piasecki, Mathew
    Antebi, Adam
    Lynch, Gordon S.
    Philp, Andrew
    Vanapalli, Siva A.
    Whiteman, Matthew
    Szewczyk, Nathaniel J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (09)
  • [32] QUANTIFYING BIREFRINGENCE IN DUCHENNE MUSCULAR DYSTROPHY ZEBRAFISH MODEL
    Yohannes, E.
    Maves, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (01) : 150 - 151
  • [33] Developing a Natural History Model for Duchenne Muscular Dystrophy
    Broomfield, Jonathan
    Hill, M.
    Chandler, F.
    Crowther, M. J.
    Godfrey, J.
    Guglieri, M.
    Hastie, J.
    Larkindale, J.
    Mumby-Croft, J.
    Reuben, E.
    Woodcock, F.
    Abrams, K. R.
    PHARMACOECONOMICS-OPEN, 2024, 8 (01) : 79 - 89
  • [34] Dysregulation of Angiogenesis in the mdx Model of Duchenne Muscular Dystrophy
    Podkalicka, Paulina
    Mucha, Olga
    Kazirod, Katarzyna
    Bronisz-Budzynska, Iwona
    Ostrowska-Paton, Sophie
    Tomczyk, Mateusz
    Dulak, Jozef
    Loboda, Agnieszka
    JOURNAL OF VASCULAR RESEARCH, 2021, 58 : 1 - 1
  • [35] The mdx mouse model as a surrogate for Duchenne muscular dystrophy
    Partridge, Terence A.
    FEBS JOURNAL, 2013, 280 (17) : 4177 - 4186
  • [36] Motor axonopathies in a mouse model of Duchenne muscular dystrophy
    Justin S. Dhindsa
    Angela L. McCall
    Laura M. Strickland
    Anna F. Fusco
    Amanda F. Kahn
    Mai K. ElMallah
    Scientific Reports, 10
  • [37] Gene therapy in the dog model for Duchenne muscular dystrophy
    MacHowell, J
    Lochmulle, H
    Fletcher, S
    OHara, A
    Massie, B
    Kakules, B
    Karpati, G
    BRAIN PATHOLOGY, 1997, 7 (04) : 1279 - 1279
  • [38] Drug screening in a zebrafish model of Duchenne muscular dystrophy
    Kawahara, Genri
    Karpf, Jeremy A.
    Myers, Jennifer A.
    Alexander, Matthew S.
    Guyon, Jeffrey R.
    Kunkel, Louis M.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (13) : 5331 - 5336
  • [39] Motor axonopathies in a mouse model of Duchenne muscular dystrophy
    Dhindsa, Justin S.
    McCall, Angela L.
    Strickland, Laura M.
    Fusco, Anna F.
    Kahn, Amanda F.
    ElMallah, Mai K.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [40] Hypoventilation in the Mdx Mouse Model of Duchenne Muscular Dystrophy
    Burns, David P.
    Arijit, Roy
    McDonald, Fiona
    Wilson, Richard J.
    O'Halloran, Ken D.
    FASEB JOURNAL, 2016, 30